News

As per the agreement, the Chinese firm will buy all of the Gland Pharma shares owned by KKR Floorline Investments apart from the shares purchased from the company's other shareholders.

In response to this, Vectura has filed a patent infringement lawsuit against GSK claiming infringement of Vectura's U.S. Patent No. 8,303,991 in the United States District Court for

The company said treatment with its tau aggregation inhibitor had a marked beneficial effect on key measures of Alzheimer's disease in patients with mild or moderate forms of

Neurovance said that CTN was within the range of the pivotal trials of approved stimulants, with a 400 mg sample of the drug demonstrating an effect size of 0.6

The approval was granted after Teva agreed to divest more than 75 generic drugs to eleven companies. The divested products will include anesthetics, antibiotics, weight loss drugs, oral

The drug was being assessed to treat acute postoperative pain in patients following bunionectomy surgery. In the phase III clinical trial, IV meloxicam achieved the primary endpoint of

Vertex will be eligible to receive milestones and royalties based on successful development and commercialization of lomibuvir and merimepodib.  Other terms were not disclosed.  "Senior management at TREKtx

The FDA had no major objections to LSKB’s global phase 3 pivotal-trial study design for apatinib in patients with advanced gastric cancer. The Company believes the plan to

Espada is a wholly-owned subsidiary of Mission Pharmacal Company (Mission) and adds breadth to Mission’s established line of dermatological drug products. Prior to this acquisition, Mission offered prescription